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Obstructive sleep apnoea (OSA) is a prevalent 
condition, affecting up to 20% of the population 
in first world countries [1]. The obstructive sleep 
apnoea hypopnea syndrome (OSAHS) is diagnosed 
when symptoms of excessive daytime somnolence 
or cognitive impairment are present in the context 
of an elevated apnoea–hypopnoea index (AHI) per 
hour of sleep. The definitions vary according to the 
lower cut-off for the AHI, which can range from >5 to 
>15 events per hour [2]. However, as with any sleep 
disorder, it is important to establish whether the sleep 
disordered breathing (SDB) per se is the true cause of 
symptoms of daytime somnolence. As is apparent to 
everyone who practises in the area, a large number 
of other factors can intervene, such as shift work, 
sleep insufficiency, psychiatric disorders, metabolic 
disorders and nutritional deficiencies, which may be 
the true cause of the somnolence rather than the 
AHI as measured on polysomnography. Additionally, 
a true AHI cannot be reported on the basis of any 
respiratory measurements conducted during sleep, 
if no electroencephalogram is simultaneously 
recorded [2].
With respect to driving, it is sleepiness while 
driving that is the greatest risk factor for road traffic 
accidents (RTAs) [3]. The risk of having a crash with 
untreated moderate to severe OSAHS is superseded 
only by age and time of day as risk factors [4]. A 
recent meta-analysis examining nine observational 
studies reviewing crash risk of drivers with OSA pre- 
versus post-continuous positive airway pressure 
(CPAP) found significant risk reduction following 
treatment (relative risk 0.278, 95% CI 0.22–0.35; 
p<0.001) [4]. Although crash data were not available 
to assess the time course of change, daytime 
sleepiness improved significantly following a single 
night of treatment with CPAP and simulated driving 
performance improved significantly within 2–7 days 
of CPAP treatment [5].
On the basis of our knowledge in this area, 
Annex III of the European Union (EU) Directive 
on Driving Licences was revised in 2014 on the 
recommendations from a working group established 
by the Transport and Mobility Directorate of the 
European Commission in 2012 [6]. The new 
directive, which was made subject to mandatory 
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implementation by all member states from 
December 31, 2015, is as follows.
1) “Applicants or drivers in whom a moderate or 
severe obstructive sleep apnea syndrome is 
suspected shall be referred to further authorised 
medical advice before a driving licence is issued 
or renewed. They may be advised not to drive 
until confirmation of the diagnosis.
2) “Driving licences may be issued to applicants 
or drivers with moderate or severe obstructive 
sleep apnea syndrome who show adequate 
control of their condition and compliance 
with appropriate treatment and improvement 
of sleepiness, if any, confirmed by authorised 
medical opinion.
3) Applicants or drivers with moderate or severe 
obstructive sleep apnea syndrome under 
treatment shall be subject to a periodic medical 
review, at intervals not exceeding 3 years for 
drivers of group 1 (i.e. non-commercial drivers) 
and 1 year for drivers of group 2 (i.e. commercial 
drivers), with a view to establish the level of 
compliance with the treatment, the need for 
continuing the treatment and continued good 
vigilance.”
Furthermore, the terms used in the amendment 
are defined as follows.
1) “… Moderate obstructive sleep apnoea 
syndrome corresponds to a number of 
apnoeas and hypopnoeas per hour (Apnoea-
Hypopnoea Index) between 15 and 29 and 
a severe obstructive sleep apnoea syndrome 
corresponds to an Apnoea-Hypopnoea Index 
of 30 or more, both associated with excessive 
daytime sleepiness.
2) “Applicants or drivers in whom a moderate 
or severe obstructive sleep apnoea syndrome 
is suspected shall be referred for further 
authorised medical advice before a driving 
licence is issued or renewed. They may be 
advised not to drive until confirmation of the 
diagnosis.
3) “Driving licences may be issued to applicants 
or drivers with moderate or severe obstructive 
sleep apnoea syndrome who show adequate 
control of their condition and compliance 
with appropriate treatment and improvement 
of sleepiness, if any, confirmed by authorised 
medical opinion.
4) “Applicants or drivers with moderate or severe 
obstructive sleep apnoea syndrome under 
treatment shall be subject to a periodic medical 
review, at intervals not exceeding three years 
for drivers of group 1 and one year for drivers 
of group 2, with a view to establish the level of 
compliance with the treatment, the need for 
continuing the treatment and continued good 
vigilance.”
In a clinical setting, the patient who presents 
with symptoms consistent with OSA (snoring, 
choking arousals and witnessed apnoeas) will 
require assessment for excessive daytime 
sleepiness. This is generally undertaken by way 
of subjective questionnaires, such as the Epworth 
Sleepiness Scale (ESS) [7]. These methods of 
assessing sleepiness are susceptible to reporting 
bias, particularly by professional drivers who 
may seek to underestimate severity. Objective 
evaluation is expensive, time consuming and not 
well suited to being performed on a large scale 
[1]. Probably, the most commonly performed 
test for assessing treatment effectiveness is the 
maintenance of wakefulness test (MWT), which 
in no respect replicates real-life driving situations 
and is often restricted to large sleep centres. The 
test is time-consuming and expensive. Additionally, 
the correlation between the results of the MWT 
and accidents is very weak [8]. Driving simulators 
may not uniformly assess skills on the road and are 
likewise not in widespread clinical use [4, 5].
Application of European 
Union Directive 2014/85/EU 
in the UK
In the UK, the Driver and Vehicle Licensing Agency 
(DVLA) have recently changed their advice regarding 
who should not drive and who needs to notify them 
(table 1) [9]. The DVLA seems to have interpreted 
the EU directive in a way that has caused some 
consternation amongst both patients and clinicians 
(multiple personal communications). The DVLA 
have moved away from the idea of being informed 
only when there is sufficient sleepiness to impair 
driving to a combination of the former along with 
generalised sleepiness and severity of SDB based 
on AHI. The guidance has also become more 
confusing with the introduction of “obstructive 
sleep apnoea syndrome” (OSAS) as a diagnosis for 
which they are to be notified even without a degree 
of sleepiness that might impair driving. If somebody 
has “excessive sleepiness” but has mild OSAS (AHI 
5–15), they must stop driving until sleepiness has 
been controlled but they do not have to inform the 
DVLA unless they are a bus or heavy goods vehicle 
(HGV) driver. However, the same patient with an 
AHI of >15 would have to inform the DVLA. To 
complicate matters, the latter patient must inform 
the DVLA and stop driving when this diagnosis is 
suspected, rather than after confirmation. On this 
basis, if a clinician suspects that their patient has 
moderate or severe OSAS (but not mild) they should 
be advised to stop driving and inform the DVLA. If 
a patient is diagnosed with moderate or severe 
OSA but does not have sleepiness they also should 
not drive until “associated symptoms” like “poor 
concentration” are controlled. However, they do not 
have to inform the DVLA even if they are HGV drivers.
The evidence base of such advice is limited. 
While there is no dearth of evidence supporting 
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that, on average, OSA sufferers are more likely to 
be involved in RTAs, there is conflicting evidence 
in terms of the association between RTA and 
generalised sleepiness due to OSA as assessed by 
the ESS [4, 10–12]. Similarly, none of the studies 
have shown any definite relationship between an 
increased incidence of RTAs with more severe SDB 
[12, 13]. There have been some data to suggest 
that assessing sleepiness while driving might be 
more useful in assessing the risk of RTA [14]. The 
American Thoracic Society and the British Thoracic 
Society have based their fitness to drive advice on 
this aspect [15, 16].
Assessing individual driving risk is difficult. 
Traditional objective tests of excessive daytime 
sleepiness like the MWT or OSLER do not represent 
a complex task like driving. Similarly, tests using 
simple driving simulators do not reliably replicate 
real driving and are insufficiently sensitive to identify 
individual “at-risk” drivers [17, 18]. More recently, 
using advanced office-based driving simulators with 
more realistic graphics and controls it has been 
shown that it is possible to identify a subgroup of 
OSA sufferers with a higher degree of accuracy who 
would perform worse than others (area under the 
receiver operating characteristic curve 0.93) [19–
21]. However, no simulation can fully replicate real 
life. Real-life accidents occur due to a multitude of 
causes, not just sleepiness. Hence, like everything 
else in medicine, an individual risk assessment 
remains a combination of detailed history and 
certain investigations.
In practise, a detailed history should include 
a thorough assessment of a patient’s perception 
of any problems with driving. Patients should be 
asked about any sleepiness while driving in different 
driving situations (e.g. on motorways or urban 
roads, and at different times of day). Any history of 
nodding off at the wheel should be explored and 
the circumstances of such an incident probed. 
Patients should be specifically asked about how 
long they can drive on a motorway without a 
break. Any history of accidents should be explored, 
focussing on the circumstances leading up to it. 
A patient’s insight into these problems has to be 
assessed; for example, a patient might say they do 
feel sleepy at times and they would routinely pull 
over for a rest while another patient might admit 
to feeling sleepy in the afternoons but prefer to 
finish the drive in one go. The type of driving is also 
important; for example, somebody who commutes 
short distances on urban roads might be at lower 
risk than someone who drives regularly on the 
motorway. This information has to be combined 
with other methods of assessing OSA like the ESS 
and objective measurement of the severity of SDB. 
While it is possible that some patients might not 
be as forthcoming with any problems while driving 
due to worries about losing their licence, assessing 
the risk from multiple angles should increase the 
Table 1 Excessive sleepiness, including obstructive sleep apnoea syndrome
Group 1: car and motorcycle Group 2: bus and lorry
Excessive sleepiness
including due to mild obstructive 
sleep apnoea syndrome
AHI <15 (mild) on the or equivalent 
sleep study measure
Must not drive but may not need to notify 
the DVLA
Driving may resume only after satisfactory 
symptom control
Must not drive and must notify the DVLA
Driving may be licensed again once 
control of symptoms is satisfactory
The DVLA will require a specialist’s 
confirmation of ongoing adherence to 
treatment
Licensing is subject to review, usually 
annually
Obstructive sleep apnoea syndrome, 
moderate and severe apnoeas with 
sleepiness
AHI 15–29 (moderate) or ≥30 (severe) 
or equivalent sleep study measure
Must not drive and must notify the DVLA
This requirement also applies for a 
suspected diagnosis yet to be confirmed
Subsequent licensing will require
 control of condition
 sleepiness improved
 treatment adherence 
The DVLA will need medical confirmation 
of the above, and the driver must 
confirm review to be undertaken every 
annually at the minimum
Must not drive and must notify the DVLA 
This requirement also applies for a 
suspected diagnosis yet to be confirmed
Subsequent licensing will require 
 control of condition
 sleepiness improved
 treatment adherence 
The DVLA will need medical confirmation 
of the above, and the driver must 
confirm review to be undertaken every 3 
years at the minimum
Obstructive sleep apnoea, moderate 
and severe apnoeas without 
sleepiness 
AHI 15–29 (moderate) or ≥30 (severe) 
or equivalent sleep study measure
Must not drive but need not notify the 
DVLA
Driving may resume once associated 
symptoms such as poor concentration 
have been brought under control
Must not drive but need not notify the 
DVLA
Driving may resume once associated 
symptoms such as poor concentration 
have been brought under control
Reproduced and modified from [9] with permission from the publisher.
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chance of picking up an issue. A recent study has 
shown that a subject is much more likely to fail 
a simulated driving test if they have admitted to 
nodding off at the wheel (p=0.014), feeling highly 
sleepy while driving (p=0.006) or taking a break at 
less than an hour of driving (p<0.001) suggesting 
some correlation between real life and simulated 
performance [22]. There was correlation with higher 
ESS (p=0.04) but the correlation with severity of OSA 
(p=0.08) and real-life accidents (p=0.09) stopped 
short of statistical significance.
In conclusion, an OSA patient’s risk of having a 
RTA should be assessed using detailed driving history 
with a specific focus on the “red flags” (table 2). 
The driving regulatory authorities should take this 
into account while issuing their guidance. While 
allowing a driver who is not safe to drive can have 
potentially disastrous consequences, preventing 
a person who is as safe as anybody else in the 
community can have significant consequences in 
terms of their employment and quality of life. It also 
risks driving the problem underground with people 
not coming forward with suspected OSA for fear of 
losing their licence. Finally, it is important to note 
that one clinician’s comprehensive risk assessment 
of driving may lead to a different conclusion from 
that of another. This is unavoidable, but if there 
are large discrepancies this may lead to significant 
dissatisfaction from patients [23].
Currently, the British Sleep Society and the British 
Thoracic Society are attempting to negotiate 
with the DVLA regarding the guidance issued 
in response to the EU directive. Driving risk has 
been based purely on the severity of SDB without 
defining excessive daytime sleepiness. Failure 
to include a specialist in the area of SDB on the 
DVLA panel when revising the advice or to consult 
with clinicians working in this area has lead to 
confusing and contradictory guidelines, and throws 
into question the concept of “authorised medical 
advice”. The European Respiratory Society has 
established a task force in the area of driving and 
OSA to develop guidance and help ensure that any 
adoption of EU directive 2014/85/EU is undertaken 
in a reasoned, sustainable and fair manner in line 
with each country’s legislative procedures and 
economic resources [24, 25].
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